|
|
- ICD-O-3 SEER Site/Histology Validation List - 06/21/2004 - updated from 2/9/2001
- This site/type list is provided in both PDF (*.pdf) and Excel (*.xls) formats: [sitetype.d06212004.pdf]
[sitetype.d06212004.xls]. The PDF file is intended as a reference file
for ICD-O-3 only. Although based on the 2/9/2001 Validation List, it has been stripped of redlining and strikeouts.
The errata sheets provided below document updates since 2/9/2001.
- ICD-O-3 Hematopoietic Primaries Table (PDF) - 3/15/2001
- The hematopoietic primaries table indicates whether two hematopoietic
diseases (such as a lymphoma and a leukemia) diagnosed separately and coded in ICD-O-3
should be considered the same primary (S) or different primaries (D). The table is based
on current medical understanding of these diseases as they are listed in ICD-O-3. This
table replaces pages 15-37 in the SEER Program Code Manual (3rd edition, 1998)
for cases diagnosed on or after January 1, 2001. This table replaces Appendix B of
the Commission on Cancer's ROADS manual for cases diagnosed on or after January 1, 2001.
- Clarifications for Abstracting and Coding Hematopoietic Diseases (PDF) - 5/22/2001
- Explanation of what therapies are used for the hematopoietic diseases
and how they should be coded in the treatment fields, further description of the hematopoietic
primaries table, and additional clarifications specific to the hematopoietic diseases.
- ICD-O-3 Errata and Clarifications
- Corrections for both the soft cover and hard cover versions of
ICD-O-3 and further discussion of issues that were not well described in the printed
editions of ICD-O-3
- Complex morphologies (PDF) - 10/02/2002
- Clarifications to SEER rules for coding cases with multiple cell types in a single tumor and other histology coding dilemmas.
|
|
Surveillance Research Program
Division of Cancer Control &
